πŸ‡ΊπŸ‡Έ FDA
Patent

US 12421193

GPR52 modulators and methods of use

granted A61PA61P25/00

Quick answer

US patent 12421193 (GPR52 modulators and methods of use) held by Neurocrine Biosciences, Inc. expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Neurocrine Biosciences, Inc.
Grant date
Tue Sep 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61P, A61P25/00